Last updated 10 days ago

Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)

400 patients around the world
Available in Spain, Brazil, Argentina, Mexico, United States
Amgen
15Research sites
400Patients around the world
This study is for people with
Lung cancer
Small cell lung carcinoma
Requirements for the patient
From 18 Years
All Gender
Medical requirements
Sites
Hospital Alemán
Av. Pueyrredón 1640, CABA, Buenos Aires
Hospital Italiano de La Plata
Av. 51 entre 29 y 30 Nro 1725, La Plata, Buenos Aires
Instituto Oncológico de Córdoba IONC - Fundación Richardet Longo
Paraná 560, Córdoba
Sanatorio 9 de Julio - Tucumán
Sanatorio 9 de Julio - Tucumán
San Juan 537, San Miguel de Tucumán, CP 4000
Fundación Respirar
Av. Cabildo 1548, CABA, Buenos Aires
Hospital Santa Rita
Av. Mal. Campos, 1579 - Nazareth, Vitória - ES, 29043-260, Brazil
Hospital Do Cancer de Londrina
Londrina, 86015-520
CIPO - Centro Integrado de Pesquisa em Oncologia
Av. Francisco Trein, 596 - 3140 e - Cristo Redentor, Porto Alegre - RS, 91350-200, Brazil
Hospital Ana Nery
R. Amapá, 175 - Ana Nery, Santa Cruz do Sul - RS, 96835-100, Brazil
Hospital de Câncer de Barretos - Fundação PIO XII
Rua Antenor Duarte Villela 1331 - Barretos, Sao Paulo, 14784-400
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy